Search details
1.
Immunogenicity and efficacy of the novel cancer vaccine based on simian adenovirus and MVA vectors alone and in combination with PD-1 mAb in a mouse model of prostate cancer.
Cancer Immunol Immunother
; 65(6): 701-13, 2016 06.
Article
in English
| MEDLINE | ID: mdl-27052571
2.
Phenotype and Reactivity of Lymphocytes Expanded from Benign Prostate Hyperplasic Tissues and Prostate Cancer.
Cancers (Basel)
; 15(12)2023 Jun 08.
Article
in English
| MEDLINE | ID: mdl-37370724
3.
Heterologous prime-boost vaccination targeting MAGE-type antigens promotes tumor T-cell infiltration and improves checkpoint blockade therapy.
J Immunother Cancer
; 9(9)2021 09.
Article
in English
| MEDLINE | ID: mdl-34479921
4.
Safety and immunogenicity of novel 5T4 viral vectored vaccination regimens in early stage prostate cancer: a phase I clinical trial.
J Immunother Cancer
; 8(1)2020 06.
Article
in English
| MEDLINE | ID: mdl-32591433
5.
Vaccination of colorectal cancer patients with modified vaccinia ankara encoding the tumor antigen 5T4 (TroVax) given alongside chemotherapy induces potent immune responses.
Clin Cancer Res
; 13(15 Pt 1): 4487-94, 2007 Aug 01.
Article
in English
| MEDLINE | ID: mdl-17671134
6.
Vaccination of colorectal cancer patients with modified vaccinia Ankara delivering the tumor antigen 5T4 (TroVax) induces immune responses which correlate with disease control: a phase I/II trial.
Clin Cancer Res
; 12(11 Pt 1): 3416-24, 2006 Jun 01.
Article
in English
| MEDLINE | ID: mdl-16740766
7.
5T4 oncofoetal glycoprotein: an old target for a novel prostate cancer immunotherapy.
Oncotarget
; 8(29): 47474-47489, 2017 Jul 18.
Article
in English
| MEDLINE | ID: mdl-28537896
8.
The Human Vaccines Project: A roadmap for cancer vaccine development.
Sci Transl Med
; 8(334): 334ps9, 2016 Apr 13.
Article
in English
| MEDLINE | ID: mdl-27075624
9.
Monitoring of human immunological responses to vaccinia virus.
Methods Mol Biol
; 269: 243-66, 2004.
Article
in English
| MEDLINE | ID: mdl-15114020
10.
Vaccination of colorectal cancer patients with TroVax given alongside chemotherapy (5-fluorouracil, leukovorin and irinotecan) is safe and induces potent immune responses.
Cancer Immunol Immunother
; 57(7): 977-86, 2008 Jul.
Article
in English
| MEDLINE | ID: mdl-18060404
11.
Active treatment of murine tumors with a highly attenuated vaccinia virus expressing the tumor associated antigen 5T4 (TroVax) is CD4+ T cell dependent and antibody mediated.
Cancer Immunol Immunother
; 55(9): 1081-90, 2006 Sep.
Article
in English
| MEDLINE | ID: mdl-16311730
12.
Identification of a major histocompatibility complex class I-restricted T-cell epitope in the tumour-associated antigen, 5T4.
Immunology
; 118(1): 50-7, 2006 May.
Article
in English
| MEDLINE | ID: mdl-16630022
Results
1 -
12
de 12
1
Next >
>>